Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
9 Tips for Avoiding Tax Season Cyber Scams
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Explosion and Fire Erupt at Valero Oil Refinery in Port Arthur, Texas
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 



